While Alto Neuroscience Inc has overperformed by 0.41%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ANRO rose by 304.26%, with highs and lows ranging from $17.60 to $1.60, whereas the simple moving average jumped by 230.49% in the last 200 days.
On November 17, 2025, BTIG Research started tracking Alto Neuroscience Inc (NYSE: ANRO) recommending Buy. A report published by Chardan Capital Markets on September 29, 2025, Initiated its previous ‘Buy’ rating for ANRO. Wedbush also Downgraded ANRO shares as ‘Neutral’, setting a target price of $4 on the company’s shares in a report dated October 23, 2024. Wedbush initiated its ‘Outperform’ rating for ANRO, as published in its report on September 03, 2024. TD Cowen also rated the stock as ‘Outperform’.
Analysis of Alto Neuroscience Inc (ANRO)
Alto Neuroscience Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -45.01% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 15.42, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and ANRO has an average volume of 1.64M. On a monthly basis, the volatility of the stock is set at 8.75%, whereas on a weekly basis, it is put at 10.74%, with a gain of 29.06% over the past seven days. Furthermore, long-term investors anticipate a median target price of $30.55, showing growth from the present price of $17.1, which can serve as yet another indication of whether ANRO is worth investing in or should be passed over.
How Do You Analyze Alto Neuroscience Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 10.34%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 69.32% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
